Amyris partners with IDRI on scalable vaccine platform

By The Science Advisory Board staff writers

July 27, 2020 -- Amyris and the Infectious Disease Research Institute (IDRI) have inked a binding term sheet for the development of a planned COVID-19 RNA vaccine technology platform.

The program will utilize IRDI's expertise in infectious diseases with Amyris' fermentation platform technology to create semisynthetic squalene-based adjuvants at scale.

The IDRI is a nonprofit global health organization that works to develop solutions for infectious diseases. IDRI's vaccine platform uses a replicating RNA molecule to express viral antigens, formulated and delivered to injection sites with a nanostructured lipid carrier system that can be stockpiled for use in future epidemic situations.

The fermentation platform replaces shark-based squalene with lower-cost sugarcane-derived squalene. Amyris' squalene adjuvant has the potential to provide large quantities to meet demand for COVID-19 vaccines. The sugarcane squalene will be certified in the late stages of commercialization.

Currently, Amyris and IDRI are working informally to advance the vaccine at an accelerated timeline. The organizations anticipate the execution of a comprehensive agreement where details of the program will be formally disclosed.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here